Related Experiment Video
Updated: May 8, 2026

Generation of a RIP1 Knockout U937 Cell Line Using the CRISPR-Cas9 System
Published on: April 11, 2025
Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains
1College of Biological Sciences, China Agricultural University, Beijing 100094, China.
Abstract:
The tumour necrosis factor (TNF) family is crucial for immune homeostasis, cell death and inflammation. These cytokines are recognized by members of the TNF receptor (TNFR) family of death receptors, including TNFR1 and TNFR2, and FAS and TNF-related apoptosis-inducing ligand (TRAIL) receptors. Death receptor signalling requires death-domain-mediated homotypic/heterotypic interactions between the receptor and its downstream adaptors, including TNFR1-associated death domain protein (TRADD) and FAS-associated death domain protein (FADD). Here we discover that death domains in several proteins, including TRADD, FADD, RIPK1 and TNFR1, were directly inactivated by NleB, an enteropathogenic Escherichia coli (EPEC) type III secretion system effector known to inhibit host nuclear factor-κB (NF-κB) signalling. NleB contained an unprecedented N-acetylglucosamine (GlcNAc) transferase activity that specifically modified a conserved arginine in these death domains (Arg 235 in the TRADD death domain). NleB GlcNAcylation (the addition of GlcNAc onto a protein side chain) of death domains blocked homotypic/heterotypic death domain interactions and assembly of the oligomeric TNFR1 complex, thereby disrupting TNF signalling in EPEC-infected cells, including NF-κB signalling, apoptosis and necroptosis. Type-III-delivered NleB also blocked FAS ligand and TRAIL-induced cell death by preventing formation of a FADD-mediated death-inducing signalling complex (DISC). The arginine GlcNAc transferase activity of NleB was required for bacterial colonization in the mouse model of EPEC infection. The mechanism of action of NleB represents a new model by which bacteria counteract host defences, and also a previously unappreciated post-translational modification.
Insights
Enteropathogenic Escherichia coli uses NleB to inhibit host immune responses by modifying death domains, blocking crucial cell signaling pathways like NF-κB, apoptosis, and necroptosis. This bacterial mechanism, involving N-acetylglucosamine transferase activity, is vital for infection.
Area of Science:
- Microbiology
- Immunology
- Molecular Biology
Background:
- Tumor Necrosis Factor (TNF) signaling is critical for immune homeostasis, inflammation, and cell death.
- TNF receptor (TNFR) family members, like TNFR1 and FAS, mediate these signals through death domains.
- These domains interact with adaptor proteins such as TRADD and FADD to trigger downstream signaling.
Purpose of the Study:
- To identify the mechanism by which enteropathogenic Escherichia coli (EPEC) inhibits host immune signaling.
- To investigate the role of the EPEC type III secretion system effector NleB in modulating death receptor pathways.
- To characterize the enzymatic activity of NleB and its impact on host cell death and inflammation.
Main Methods:
- Biochemical assays to determine NleB's enzymatic activity.
- Site-directed mutagenesis to identify key residues in NleB and target death domains.
- Cell-based assays to assess NF-κB signaling, apoptosis, and necroptosis.
- In vivo infection models to evaluate the role of NleB in bacterial colonization.
Main Results:
- NleB possesses N-acetylglucosamine (GlcNAc) transferase activity, modifying a conserved arginine in death domains of proteins including TRADD, FADD, RIPK1, and TNFR1.
- This GlcNAcylation inactivates death domains, preventing essential protein-protein interactions and the assembly of signaling complexes like the TNFR1 complex and DISC.
- Disruption of TNF, NF-κB, apoptosis, and necroptosis signaling was observed in EPEC-infected cells.
- NleB's GlcNAc transferase activity was essential for EPEC colonization in a mouse model.
Conclusions:
- NleB from EPEC directly inhibits host TNFR and FAS signaling pathways through a novel post-translational modification (GlcNAcylation) of death domains.
- This bacterial strategy effectively counteracts host immune responses, including inflammation and cell death.
- The discovery of NleB's arginine GlcNAc transferase activity reveals a new mechanism of bacterial pathogenesis and an unappreciated form of protein modification.
Related Concept Videos
The Extrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Amplifying Signals via Enzymatic Cascade
The JAK-STAT Signaling Pathway
GPCR Desensitization
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
